MedTrace Logo

Image Guided and Breathing Adapted Radiotherapy of Early Stage Lung Cancer

NCT00910546 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 15

Last updated 2021-02-26

No results posted yet for this study

Summary

The purpose of this study is to quantify the variation in tumour middle position during a course of stereotactic body radiotherapy (SBRT), and thereby be able to design radiotherapy margins that takes into account the full motion span throughout an entire course of SBRT.

Conditions

Interventions

DEVICE

visicoil gold marker 0.7 x 20 mm

CT - guided implantation into lung tumors

Sponsors & Collaborators

  • Gitte Fredberg Persson

    lead OTHER

Principal Investigators

  • Gitte F Persson, MD · Rigshospitalet, Denmark

  • Ditte E Nygaard, MSc · Rigshospitalet, Denmark

  • Stine S Korreman, MSc PhD · Rigshospitalet, Denmark

  • Lena Specht, MD DMSc · Rigshospitalet, Denmark

Study Design

Allocation
NA
Purpose
BASIC_SCIENCE
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
40 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2009-02-28
Primary Completion
2011-04-30
Completion
2011-04-30

Countries

  • Denmark

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00910546 on ClinicalTrials.gov